Cargando…
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
PURPOSE: We investigated the utility of the Oncomine Breast cfDNA Assay for detecting circulating tumor DNA (ctDNA) in women from a breast screening population, including healthy women with no abnormality detected by mammogram, and women on follow-up through to advanced breast cancer. MATERIALS AND...
Autores principales: | Page, Karen, Martinson, Luke J., Fernandez-Garcia, Daniel, Hills, Allison, Gleason, Kelly L. T., Gray, Molly C., Rushton, Amelia J., Nteliopoulos, Georgios, Hastings, Robert K., Goddard, Kate, Ions, Charlotte, Parmar, Vilas, Primrose, Lindsay, Openshaw, Mark R., Guttery, David S., Palmieri, Carlo, Ali, Simak, Stebbing, Justin, Coombes, R. Charles, Shaw, Jacqueline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624092/ https://www.ncbi.nlm.nih.gov/pubmed/34849446 http://dx.doi.org/10.1200/PO.20.00522 |
Ejemplares similares
-
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer
por: Fernandez-Garcia, Daniel, et al.
Publicado: (2022) -
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients
por: Nteliopoulos, Georgios, et al.
Publicado: (2021) -
A Review of Circulating Tumour Cell Enrichment Technologies
por: Rushton, Amelia J., et al.
Publicado: (2021) -
Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids
por: Page, Karen, et al.
Publicado: (2013) -
Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)
por: Stebbing, Justin, et al.
Publicado: (2023)